BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 22572478)

  • 1. Transient impairment of NK cell function in an infant born to a mother with adult-onset Still's disease: perinatal effect of maternal IL-18.
    Shimizu M; Sakakibara Y; Kawano M; Yachie A
    Clin Immunol; 2012 Jun; 143(3):273-4. PubMed ID: 22572478
    [No Abstract]   [Full Text] [Related]  

  • 2. Successful treatment with tacrolimus of refractory adult-onset Still's disease.
    Ohe M; Oku K; Kono M; Bohgaki T
    Korean J Intern Med; 2014 Mar; 29(2):259-61. PubMed ID: 24648814
    [No Abstract]   [Full Text] [Related]  

  • 3. Adult-onset Still's disease and myocarditis: successful treatment with intravenous immunoglobulin and maintenance of remission with etanercept.
    Kuek A; Weerakoon A; Ahmed K; Ostör AJ
    Rheumatology (Oxford); 2007 Jun; 46(6):1043-4. PubMed ID: 17449487
    [No Abstract]   [Full Text] [Related]  

  • 4. Lymph node IL-18 expression in adult-onset Still's disease.
    Conigliaro P; Priori R; Bombardieri M; Alessandri C; Barone F; Pitzalis C; McInnes IB; Valesini G
    Ann Rheum Dis; 2009 Mar; 68(3):442-3. PubMed ID: 19213748
    [No Abstract]   [Full Text] [Related]  

  • 5. Pathogenesis and management of adult-onset Still's disease.
    Efthimiou P; Georgy S
    Semin Arthritis Rheum; 2006 Dec; 36(3):144-52. PubMed ID: 16949136
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Blockade of interleukin 1 receptor in Still's disease affects activation of peripheral T-lymphocytes.
    Youssef J; Lazaro E; Blanco P; Viallard JF
    J Rheumatol; 2008 Dec; 35(12):2453-6. PubMed ID: 19143047
    [No Abstract]   [Full Text] [Related]  

  • 7. IL-1 Trap rilonacept in refractory adult onset Still's disease.
    Petryna O; Cush JJ; Efthimiou P
    Ann Rheum Dis; 2012 Dec; 71(12):2056-7. PubMed ID: 22679302
    [No Abstract]   [Full Text] [Related]  

  • 8. Adult-onset Still's disease with macrophage activation syndrome successfully treated with a combination of methotrexate and etanercept.
    Maeshima K; Ishii K; Iwakura M; Akamine M; Hamasaki H; Abe I; Haranaka M; Tatsukawa H; Yoshimatsu H
    Mod Rheumatol; 2012 Feb; 22(1):137-41. PubMed ID: 21670967
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prolonged treatment with Tadekinig alfa in adult-onset Still's disease.
    Kiltz U; Kiefer D; Braun J; Schiffrin EJ; Girard-Guyonvarc'h C; Gabay C
    Ann Rheum Dis; 2020 Jan; 79(1):e10. PubMed ID: 30352887
    [No Abstract]   [Full Text] [Related]  

  • 10. Interleukin-18 as a diagnostic marker of adult-onset Still's disease in older patients: a case report and review of the literature.
    Usuda D; Furumura Y; Takeshima K; Sangen R; Kawai Y; Kasamaki Y; Iinuma Y; Kanda T
    J Med Case Rep; 2018 Jul; 12(1):198. PubMed ID: 29986752
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A case of refractory adult-onset Still's disease with high serum interleukin-18 levels treated with monitoring of serum levels of cyclosporine.
    Horai Y; Koyama A; Miyamura T; Hirata A; Nakamura M; Ando H; Takahama S; Minami R; Yamamoto M; Suematsu E
    Fukuoka Igaku Zasshi; 2012 Jan; 103(1):24-8. PubMed ID: 22423500
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of thalidomide in refractory adult Still's disease: a new case report.
    Meaux-Ruault N; Magy N; Gil H; Dupond JL
    Clin Exp Rheumatol; 2003; 21(2):272. PubMed ID: 12747295
    [No Abstract]   [Full Text] [Related]  

  • 13. Exacerbation of adult-onset Still's disease, possibly related to elevation of serum tumor necrosis factor-alpha after etanercept administration.
    Kaneko K; Kaburaki M; Muraoka S; Tanaka N; Yamamoto T; Kusunoki Y; Abe H; Endo H; Kawai S
    Int J Rheum Dis; 2010 Oct; 13(4):e67-9. PubMed ID: 21199457
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adult-onset Still's disease: can recent advances in our understanding of its pathogenesis lead to targeted therapy?
    Efthimiou P; Kontzias A; Ward CM; Ogden NS
    Nat Clin Pract Rheumatol; 2007 Jun; 3(6):328-35. PubMed ID: 17538564
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Myocarditis in adult-onset Still's disease despite significant immunosuppressive therapy.
    Kristensen LE; Bartosik I
    Scand J Rheumatol; 2006; 35(4):330-1. PubMed ID: 16882603
    [No Abstract]   [Full Text] [Related]  

  • 16. Interleukin-18 as a novel diagnostic marker and indicator of disease severity in adult-onset Still's disease.
    Kawaguchi Y; Terajima H; Harigai M; Hara M; Kamatani N
    Arthritis Rheum; 2001 Jul; 44(7):1716-7. PubMed ID: 11465725
    [No Abstract]   [Full Text] [Related]  

  • 17. [Adult Still's disease: recent progress in basic and clinical research].
    Ohta A
    Nihon Rinsho; 2005 May; 63 Suppl 5():289-94. PubMed ID: 15954364
    [No Abstract]   [Full Text] [Related]  

  • 18. [A case report of pregnancy complicated with adult Still's disease].
    Yunohara N; Matsuda Y; Kamitomo M; Hatae M
    Nihon Sanka Fujinka Gakkai Zasshi; 1996 Jun; 48(6):431-4. PubMed ID: 8752706
    [No Abstract]   [Full Text] [Related]  

  • 19. Anakinra in patients with treatment-resistant adult-onset Still's disease: four case reports with serial cytokine measurements and a review of the literature.
    Kötter I; Wacker A; Koch S; Henes J; Richter C; Engel A; Günaydin I; Kanz L
    Semin Arthritis Rheum; 2007 Dec; 37(3):189-97. PubMed ID: 17583775
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adult Still's disease reflects a Th2 rather than a Th1 cytokine profile.
    Saiki O; Uda H; Nishimoto N; Miwa T; Mima T; Ogawara T; Azuma N; Katada Y; Sawaki J; Tsutsui H; Matsui K; Maeda A; Nakanishi K
    Clin Immunol; 2004 Jul; 112(1):120-5. PubMed ID: 15207789
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.